30 Apr Topiramate – Risk of Neurodevelopment Disorders Associated With Use in Pregnancy
Posted at 10:10h
in
Janssen Pharmaceutica (Pty) Ltd, in collaboration with the South African Health Products Regulatory Authority (SAHPRA) would like to inform you of the risk of neurodevelopment disorders (NDDs) associated with topiramate use in pregnancy.
Download latest version
Document Number:
DHCPL
Version:
1
Date Updated:
21/04/2026
File Type:
www
Category:
Communication To Health Care Professionals